Related Experiment Video
Updated: Aug 17, 2025

06:59
Quantification of Atherosclerosis in Mice
Published on: June 12, 2019
37.9K
Mendelian Randomization Study Does Not Support a Bidirectional Link between Atherosclerosis and Venous
Mengjin Hu1, Zhaoting Gong1, Yuejin Yang1
1State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College.
Journal of Atherosclerosis and Thrombosis
|December 18, 2022
Summary
This study found no causal link between coronary heart disease (CHD) and venous thromboembolism (VTE). Arterial and venous thromboses appear to be distinct conditions, challenging previous assumptions.
Area of Science:
- Cardiovascular Science
- Genetics
- Epidemiology
Background:
- Observational studies suggest a link between atherosclerosis and venous thromboembolism (VTE), but findings are conflicting.
- Establishing a causal relationship between coronary heart disease (CHD) and VTE, deep venous thrombosis (DVT), and pulmonary embolism (PE) is crucial.
Approach:
- Utilized Mendelian randomization (MR) analyses to investigate bidirectional causality between CHD and VTE, DVT, and PE.
- Employed genetic instruments from large-scale consortia (CARDIoGRAMplusC4D and FinnGen) with robust statistical methods, including inverse-variance weighted meta-analysis and complementary MR techniques.
- Adjusted for potential confounders like body mass index in multivariable MR analyses.
Key Points:
- MR analyses revealed no significant causal relationship between genetically predicted VTE, DVT, or PE and CHD.
- Conversely, genetically predicted CHD did not demonstrate a causal effect on VTE, DVT, or PE.
- No evidence of pleiotropic bias was detected, and heterogeneity was addressed using a random-effect model.
Conclusions:
- This study provides strong evidence against a causal association between coronary heart disease and venous thromboembolism.
- The findings suggest that arterial and venous thrombotic events may be driven by independent pathophysiological mechanisms.
Related Concept Videos
Randomized Experiments
7.1K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
7.1K
Venous Thrombosis I: Introduction
23
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
23
What is an Experiment?
11.9K
An experiment is a planned activity carried out under controlled conditions. The purpose of an experiment is to investigate the relationship between two variables. When one variable causes change in another, we call the first variable the explanatory or independent variable. The affected variable is called the response or dependent variable. In a randomized experiment, the researcher manipulates values of the explanatory variable and measures the resulting changes in the response variable. The...
11.9K
Atherosclerosis I: Introduction
34
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
34
Genome-wide Association Studies-GWAS
13.9K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.9K
Atherosclerosis III: Management
19
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
19

